Login to Your Account



Pharma: Other News To Note


Tuesday, July 3, 2012
• K-V Pharmaceutical Co., of St. Louis, said the FDA provided further guidance to health care providers and pregnant women at high risk for recurrent preterm birth.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription